Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SGR-2921 by Schrodinger for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
SGR-2921 is under clinical development by Schrodinger and currently in Phase I for Relapsed Acute Myeloid Leukemia. According to GlobalData,...
SGR-2921 by Schrodinger for Refractory Acute Myeloid Leukemia: Likelihood of Approval
SGR-2921 is under clinical development by Schrodinger and currently in Phase I for Refractory Acute Myeloid Leukemia. According to GlobalData,...
SGR-2921 by Schrodinger for Myelodysplastic Syndrome: Likelihood of Approval
SGR-2921 is under clinical development by Schrodinger and currently in Phase I for Myelodysplastic Syndrome. According to GlobalData, Phase I...